Atlas Trials

R-CEOP-90/R-CEOP-70 Versus R-CHOP-50 in the Treatment of Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 3B

Clinical trial NCT01852435 · UNKNOWN

Trial details

NCT number
NCT01852435
Sponsor
Ruijin Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Diffuse Large B-cell LymphomaFollicular Lymphoma Grade 3B
Start date
2013-05-01
Primary completion
2017-12-01
Enrollment
648

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.